by Peter Ciszewski | Jan 22, 2018
Len Walt, Vice President, Head of Medical Affairs, Sobi in North America, discusses his company’s clinical trial testing anakinra in Still’s disease, a rare inflammatory disorder. Still’s disease, a disorder featuring inflammation, is characterized...
by Peter Ciszewski | Jan 22, 2018
David Gelly, a patient with Polycythemia Vera (PV), discusses some of the resources available for this rare condition, including Voices of MPN. PVs are a group of rare blood cancers called Myeloproliferative Neoplasms (MPNs). MPNs are a group of diseases that affect...
by Peter Ciszewski | Jan 22, 2018
Roxana Sulica, MD, Associate Professor, Department of Medicine and Director, Pulmonary Hypertension at NYU Langone in New York City discusses Pulmonary arterial hypertension (PAH), a progressive condition that affects the heart and lungs. PAH is characterized by...
by Peter Ciszewski | Jan 16, 2018
Jean Tang, MD, PhD is co-founder of PellePharm and serves on the PellePharm board of directors. She is a practicing dermatologist and associate professor of dermatology at Stanford University. In this video, Dr. Tang discusses Gorlin Syndrome, a rare, genetic, disease...
by Peter Ciszewski | Jan 16, 2018
Sanuj K. Ravindran, MD is president and CEO of PellePharm. Dr. Ravindran also serves on the PellePharm Board of Directors, and is CEO-in-Residence with BridgeBio, PellePharm’s parent company. Dr. Ravindran has more than 15 years of strategic and operational biopharma...
